Claris Lifesciences Ltd vs APOLLO HOSPITALS ENTER. L

A side-by-side comparison of Claris Lifesciences Ltd (533288) and APOLLO HOSPITALS ENTER. L (APOLLOHOSP) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, APOLLO HOSPITALS ENTER. L leads 533288 vs APOLLOHOSP on 9 of 14 metrics (2 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
65.36
0.00
P/B ratio
13.42
0.00%
Dividend yield
0.11%
₹-0.05
EPS
₹135.04

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

0.00%
Return on equity
22.10%
-2.85%
Return on capital
18.00%
-18034.00%
EBITDA margin
15.00%
-15850.00%
Net margin
7.94%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

Revenue CAGR (3Y)
14.94%
Profit CAGR (3Y)
33.39%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹0 Cr
Market cap
₹1.27L Cr
₹0 Cr
Revenue
₹25,228 Cr
₹-0 Cr
Net profit
₹2,003 Cr
0.00
Debt / equity
0.90
Claris Lifesciences Ltd
  • ["Company has low interest coverage ratio."]
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 77.8% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
Claris Lifesciences Ltd full analysis APOLLO HOSPITALS ENTER. L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

Claris Lifesciences Ltd vs APOLLO HOSPITALS ENTER. L: Share Price, Valuation & Which to Buy | DocStoX